Strategy

Three strategies for managing loss of exclusivity successfully

“Patent losses could sink Allergan”.1 “Drug prices to plummet in wave of expiring patents”.2 “Price decay after loss of brand exclusivity”.3 These are just three headlines that come up when you Google “drug patent expiry”.4 It’s no wonder “loss of exclusivity (LOE)” or “the patent cliff” is an ominous prospect for drug manufacturers – shrouded …

Three strategies for managing loss of exclusivity successfully Read More »

Prescient Announces Recent Appointments to its Senior Team

Prescient hires three new senior members to expand its expertise and keep pace with the company’s growth LONDON, November 3, 2020 – Prescient, a biopharma product and portfolio strategy partner, announces the recent appointment of three new senior members: Gordon Gochenauer, Dr. Priya Kar and Dr. Cameron Mackenzie. They join the existing leadership team, which …

Prescient Announces Recent Appointments to its Senior Team Read More »

Formycon Reports BLA Resubmission Strategy for FYB201 (biosimilar, ranibizumab)

Shots: Formycon & Bioeq reported the BLA resubmission strategy for FYB201 (biosimilar referencing Lucentis) has been adjusted With the revised submission strategy, the companies expect a simplification of the approval procedure. The modified submission dossier is anticipated to be filed with the US FDA in H1’21 The adjustment of the regulatory strategy while optimizing the …

Formycon Reports BLA Resubmission Strategy for FYB201 (biosimilar, ranibizumab) Read More »

The Dawn of a European Health Data Space – Challenges

The European data strategy aims to construct common data spaces for all, create a single EU market for data, and catalyze a dynamic data economy. In a previous post, we briefly described the essence of the envisioned heath data space and pointed at opportunities and possible starting points to transform this vision into reality. However, …

The Dawn of a European Health Data Space – Challenges Read More »

Prescient Intelligence & Insight Announces Recent Appointments to the Senior Team

Prescient hires three new senior members to strengthen and grow its Intelligence & Insight business LONDON, July 15, 2020—Prescient, a biopharma product and portfolio strategy partner, announces the recent appointment of three new senior members to its Intelligence & Insight business: Dr. Anuj Gupta, Rob Littlefield and Dr. Emmanuel Reyes-Cortes. They join the existing Intelligence …

Prescient Intelligence & Insight Announces Recent Appointments to the Senior Team Read More »